Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparative Efficacy of the Polyethylene Glycol Gel and the Varying Concentrations of Benzocaine Gel in Achieving Clinically Meaningful Pain Relief in Patients with Toothache

View through CrossRef
Objective: The objective of this study was to compare meaningful pain relief with Polyethylene glycol gel, 10% and 20% concentrations of benzocaine gel in patients of toothache because of irreversible pulpitis reporting to the department of Operative Dentistry. Methodology: This comparative study was conducted from Dec 2018-Feb 2020 in the Department of Operative Dentistry, PIMS, Islamabad via stratified random sampling. Sample size was 600, 200 each for propylene glycol gel group, 10% Benzocaine group & 20% Benzocaine group. Inclusion criteria was: Patients of 15 years or more age and with-out any systemic illness, toothache because of ir-reversible pulpitis in 01 permanent mandibular or maxillary tooth having an open cavity, those patients having toothache of at-least moderate intensity as per Visual Analogue Scale (VAS). Whereas exclusion criteria were: Patients having periodontal abscess, those used any systemic or topical analgesic inside 4 hours preceding to the visit. After informed consent from participants, the ethical committee of PIMS/SZABMU approved the study Results: One-way ANOVA was used to explore the difference in time duration to achieve meaningful pain relief among the three groups, and it was found to be significant statistically (F=17.193, P<0.001). Post Hoc test was used to explore the pair wise comparisons of the three groups in terms of duration to achieve meaningful pain relief. mean difference of Group B and Group C was 2.719 and the comparison was significant (P=<0.001) and mean difference of Group C and Group A was -4.029 and the comparison was significant (P=0.001). Conclusion: Benzocaine in both concentrations is more effective in achieving clinically meaningful pain relief than Polyethylene Glycol in patients having toothache. Keywords: Benzocaine, Gel, Pain, Polyethylene Glycol, Pulpitis, Toothache
Title: Comparative Efficacy of the Polyethylene Glycol Gel and the Varying Concentrations of Benzocaine Gel in Achieving Clinically Meaningful Pain Relief in Patients with Toothache
Description:
Objective: The objective of this study was to compare meaningful pain relief with Polyethylene glycol gel, 10% and 20% concentrations of benzocaine gel in patients of toothache because of irreversible pulpitis reporting to the department of Operative Dentistry.
Methodology: This comparative study was conducted from Dec 2018-Feb 2020 in the Department of Operative Dentistry, PIMS, Islamabad via stratified random sampling.
Sample size was 600, 200 each for propylene glycol gel group, 10% Benzocaine group & 20% Benzocaine group.
Inclusion criteria was: Patients of 15 years or more age and with-out any systemic illness, toothache because of ir-reversible pulpitis in 01 permanent mandibular or maxillary tooth having an open cavity, those patients having toothache of at-least moderate intensity as per Visual Analogue Scale (VAS).
Whereas exclusion criteria were: Patients having periodontal abscess, those used any systemic or topical analgesic inside 4 hours preceding to the visit.
After informed consent from participants, the ethical committee of PIMS/SZABMU approved the study Results: One-way ANOVA was used to explore the difference in time duration to achieve meaningful pain relief among the three groups, and it was found to be significant statistically (F=17.
193, P<0.
001).
Post Hoc test was used to explore the pair wise comparisons of the three groups in terms of duration to achieve meaningful pain relief.
mean difference of Group B and Group C was 2.
719 and the comparison was significant (P=<0.
001) and mean difference of Group C and Group A was -4.
029 and the comparison was significant (P=0.
001).
Conclusion: Benzocaine in both concentrations is more effective in achieving clinically meaningful pain relief than Polyethylene Glycol in patients having toothache.
Keywords: Benzocaine, Gel, Pain, Polyethylene Glycol, Pulpitis, Toothache.

Related Results

Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
APPLICATION OF SELECTIVE HYPROMELLOSE SORBENT FOR THE BENZOCAINE QUANTITATION IN PHARMACEUTICAL FORMULATIONS
APPLICATION OF SELECTIVE HYPROMELLOSE SORBENT FOR THE BENZOCAINE QUANTITATION IN PHARMACEUTICAL FORMULATIONS
Introduction. In quality control of pharmaceutical formulations, there are methodological approaches based on the preliminary separation of sample components and approaches without...
Age–period–cohort analysis of trends in toothache prevalence among 15‐ to 64‐yr‐old Finns over a 25‐yr period
Age–period–cohort analysis of trends in toothache prevalence among 15‐ to 64‐yr‐old Finns over a 25‐yr period
Information on long‐term trends in toothache prevalence is scarce. The aim of this study was to assess age‐, period‐, and cohort‐related changes in toothache prevalence among 15‐ t...
Perianal Allergic Contact Dermatitis from Benzocaine – a Case Report
Perianal Allergic Contact Dermatitis from Benzocaine – a Case Report
Abstract A large number of contact allergic reactions to benzocaine have been reported since its introduction to the pharmaceutical market as an active ingredient...
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

Back to Top